# Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial)

> **NCT03479190** · NA · COMPLETED · sponsor: **Northumbria Healthcare NHS Foundation Trust** · enrollment: 84 (actual)

## Conditions studied

- Greater Trochanteric Pain Syndrome

## Interventions

- **PROCEDURE:** ultrasound guided injection of Platelet rich plasma
- **PROCEDURE:** ultrasound guided injection of Normal Saline

## Key facts

- **NCT ID:** NCT03479190
- **Lead sponsor:** Northumbria Healthcare NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-03
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-04-03
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03479190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03479190, "Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial)". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT03479190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*